Tubacex, S.A. TUB.MC BME · Basic materials · Spain
2.73 € -2.50% -0.07 €
Summary
40 / 100 · Bulios Score
What speaks for it
- The price moves less than the market (beta 0.48).
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 5.3 years of operating profit.
- Revenue growth is slowing: 0.2% a year over the last 3 years against 9.2% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 9.2% a year over 5 years. Over the last 3 years it grew by 0.2% a year. For the next fiscal year analysts expect revenue to fall by 5.7%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of 51.1M €.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 26.1 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.44%
- Raised in a row
- 2 years
You receive 0.04 € per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail